SHAPE CHANGES INDUCED BY BIOLOGICALLY ACTIVE PEPTIDES AND NERVE GROWTH FACTOR IN BLOOD PLATELETS OF RABBITS
Open Access
- 1 November 1981
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 74 (3) , 533-538
- https://doi.org/10.1111/j.1476-5381.1981.tb10461.x
Abstract
1 Nerve growth factor (NGF), substance P (SP) and thymopoietin all caused shape change reactions of rapid onset in rabbit platelets. NGF had the highest maximal effect, and SP the lowest EC50 (concentration causing half maximal shape change). The action of SP was reversible within 5 min, whereas that of NGF lasted for at least 1 h. A series of other peptides were inactive. 2 After preincubation of platelets with SP, a second application of SP no longer caused a shape change reaction, whereas the effect of NGF was not influenced. 3 An oxidized NGF-derivative without biological activity did not cause a shape change reaction, neither did epidermal growth factor. 4 Prostaglandin E1 (PGE1) and pretreatment of the platelets with 3% butanol, which counteract the shape changes caused by 5-hydroxytryptamine (5-HT) and adenosine 3′, 5′-diphosphate, also antagonized those induced by NGF and SP. Neither heparin nor methysergide, an antagonist of 5-HT-receptors, influenced the shape change induced by NGF or SP. The action of NGF was also antagonized by a specific antibody to NGF. 5 Thymopoietin, like the basic polypeptide polyornithine (mol. wt. 40,000), was not antagonized by PGE1 and butanol. Heparin, which counteracted the effect of polyornithine, did not influence that of thymopoietin. 6 In conclusion, different modes of action are involved in the shape change of blood platelets induced by polypeptides and proteins. SP and NGF may act by stimulating specific membrane receptors.Keywords
This publication has 22 references indexed in Scilit:
- SHAPE CHANGE OF BLOOD PLATELETS—A MODEL FOR CEREBRAL 5‐HYDROXYTRYPTAMINE RECEPTORS?British Journal of Pharmacology, 1979
- Amines inhibit the clustering of α2-macroglobulin and EGF on the fibroblast cell surfaceNature, 1979
- Reconstitution of membranes and embryonic development in dissociated blastula cells of the sea urchin by reinsertion of aggregation-promoting membrane proteins extracted with butanol.Proceedings of the National Academy of Sciences, 1979
- Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.The Journal of Physiology, 1978
- EFFECT OF GLUCOCORTICOIDS ON NERVE GROWTH FACTOR‐MEDIATED ENZYME INDUCTION IN ORGAN CULTURES OF RAT SYMPATHETIC GANGLIA: ENHANCED RESPONSE AND REDUCED TIME REQUIREMENT TO INITIATE ENZYME INDUCTIONJournal of Neurochemistry, 1977
- PURIFICATION OF NERVE GROWTH FACTOR ANTIBODIES BY AFFINITY CHROMATOGRAPHYJournal of Neurochemistry, 1976
- Topography of mouse 2.5S nerve growth factor. Reactivity of tyrosine and tryptophanBiochemistry, 1973
- Separation of isorenin activity from nerve growth factor (NGF) activity in mouse submaxillary gland extractsBiochemical Pharmacology, 1973
- Tissue culture assay of Nerve Growth Factor and of the specific antiserumExperimental Cell Research, 1970
- THE NERVE GROWTH FACTOR: PURIFICATION AS A 30,000-MOLECULAR-WEIGHT PROTEINProceedings of the National Academy of Sciences, 1969